Moreover Technologies - Biotech newsBiotech news - more than 340 categories of real-time RSS news feedsFirst Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval- (Found July 23, 2008 ) Maktoob Business Jul 22 2008 10:25PM GMThttp://c.moreover.com/click/here.pl?r1519181335 Roche Bids for Genentech: Now's the Time to Buy- (Found July 23, 2008 ) Seeking Alpha Jul 23 2008 12:20AM GMThttp://c.moreover.com/click/here.pl?r1519341024 Meridian Bioscience Update- (Found July 23, 2008 ) Seeking Alpha Jul 23 2008 12:20AM GMThttp://c.moreover.com/click/here.pl?r1519340894 Gilead initiates phase III trial of Elvitegravir- (Found July 23, 2008 ) News-Medical.Net Jul 23 2008 12:02AM GMThttp://c.moreover.com/click/here.pl?r1519313186 Biogen's Strong 2nd Quarter Helped by Tysabri Sales- (Found July 23, 2008 ) Macro World Investor Jul 22 2008 11:42PM GMThttp://c.moreover.com/click/here.pl?r1519282514 YM Biosciences Presents Data Comparing Mechanism of Action for EGFR Antibody, Nimotuzumab to Cetuximab and Panitumumab, at the Aacr Centennial Confere- (Found July 23, 2008 ) Pharma Live Jul 22 2008 11:29PM GMThttp://c.moreover.com/click/here.pl?r1519266441 Davis Polk wins lead on $43.7bn biotech takeover- (Found July 23, 2008 ) Legal Week Jul 22 2008 10:42PM GMThttp://c.moreover.com/click/here.pl?r1519205494 Roche Offers $43.7 Billion for Remaining Stake in Genentech- (Found July 23, 2008 ) FDA News Jul 22 2008 10:39PM GMThttp://c.moreover.com/click/here.pl?r1519201358 Biogen profit up 11%, Tysabri shines- (Found July 23, 2008 ) Business Spectator Jul 22 2008 10:35PM GMThttp://c.moreover.com/click/here.pl?r1519194307 Genentech CEO sells 90,000 shares prior to Roche bid- (Found July 23, 2008 ) Business Spectator Jul 22 2008 10:35PM GMThttp://c.moreover.com/click/here.pl?r1519193403 |